Viewing Study NCT03220594


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-02-25 @ 6:55 PM
Study NCT ID: NCT03220594
Status: COMPLETED
Last Update Posted: 2017-10-02
First Post: 2017-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Organization:

Study Overview

Official Title: Serum Antimullerian Hormone Levels in Patients Who Underwent Hypogastric Artery Ligation
Status: COMPLETED
Status Verified Date: 2017-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To observe the effects of hypogastric artery ligation on serum antimullerian hormone levels.
Detailed Description: To measure and compare serum antimullerian hormone levels in patients who underwent hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy and postpartum control. The procedures performed as an emergency life saving method during delivery. The reasons for hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy were obstetric hemorrhage mainly uterine atony.

The serum levels of antimullerian hormone were measured 6 months after the operations and compared with matching postpartum controls. Serum levels of FSH, LH, PRL and TSH were also measured 6 months after the operation. Further, antral follicle count measured along with the aforementioned blood tests.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: